Global and USA Meningococcal Group B Vaccine Market Insights, Forecast to 2027

Global and USA Meningococcal Group B Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Meningococcal Group B Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Group B Vaccine Market Size Growth Rate by Type
1.2.2 Bexsero
1.2.3 Trumenba
1.2.4 Other
1.3 Market by Application
1.3.1 Global Meningococcal Group B Vaccine Market Size Growth Rate by Application
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Meningococcal Group B Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Meningococcal Group B Vaccine Revenue 2016-2027
2.1.2 Global Meningococcal Group B Vaccine Sales 2016-2027
2.2 Global Meningococcal Group B Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Meningococcal Group B Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Meningococcal Group B Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Meningococcal Group B Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Meningococcal Group B Vaccine Revenue Forecast by Region (2022-2027)
3 Global Meningococcal Group B Vaccine Competitor Landscape by Players
3.1 Global Top Meningococcal Group B Vaccine Manufacturers by Sales
3.1.1 Global Meningococcal Group B Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Meningococcal Group B Vaccine Manufacturers by Revenue
3.2.1 Key Meningococcal Group B Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Meningococcal Group B Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Meningococcal Group B Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Meningococcal Group B Vaccine Revenue in 2020
3.2.6 Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Meningococcal Group B Vaccine Price by Manufacturers
3.4 Global Meningococcal Group B Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Group B Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Group B Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Meningococcal Group B Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Meningococcal Group B Vaccine Market Size by Type (2016-2021)
4.1.1 Global Meningococcal Group B Vaccine Sales by Type (2016-2021)
4.1.2 Global Meningococcal Group B Vaccine Revenue by Type (2016-2021)
4.1.3 Meningococcal Group B Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Meningococcal Group B Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Meningococcal Group B Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Meningococcal Group B Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Meningococcal Group B Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Meningococcal Group B Vaccine Market Size by Application (2016-2021)
5.1.1 Global Meningococcal Group B Vaccine Sales by Application (2016-2021)
5.1.2 Global Meningococcal Group B Vaccine Revenue by Application (2016-2021)
5.1.3 Meningococcal Group B Vaccine Price by Application (2016-2021)
5.2 Meningococcal Group B Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Meningococcal Group B Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Meningococcal Group B Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Meningococcal Group B Vaccine Price Forecast by Application (2022-2027)
6 USA by Players, Type and Application
6.1 USA Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027
6.1.1 USA Meningococcal Group B Vaccine Sales YoY Growth 2016-2027
6.1.2 USA Meningococcal Group B Vaccine Revenue YoY Growth 2016-2027
6.1.3 USA Meningococcal Group B Vaccine Market Share in Global Market 2016-2027
6.2 USA Meningococcal Group B Vaccine Market Size by Players (International and Local Players)
6.2.1 USA Top Meningococcal Group B Vaccine Players by Sales (2016-2021)
6.2.2 USA Top Meningococcal Group B Vaccine Players by Revenue (2016-2021)
6.3 USA Meningococcal Group B Vaccine Historic Market Review by Type (2016-2021)
6.3.1 USA Meningococcal Group B Vaccine Sales Market Share by Type (2016-2021)
6.3.2 USA Meningococcal Group B Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 USA Meningococcal Group B Vaccine Price by Type (2016-2021)
6.4 USA Meningococcal Group B Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 USA Meningococcal Group B Vaccine Sales Forecast by Type (2022-2027)
6.4.2 USA Meningococcal Group B Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 USA Meningococcal Group B Vaccine Price Forecast by Type (2022-2027)
6.5 USA Meningococcal Group B Vaccine Historic Market Review by Application (2016-2021)
6.5.1 USA Meningococcal Group B Vaccine Sales Market Share by Application (2016-2021)
6.5.2 USA Meningococcal Group B Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 USA Meningococcal Group B Vaccine Price by Application (2016-2021)
6.6 USA Meningococcal Group B Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 USA Meningococcal Group B Vaccine Sales Forecast by Application (2022-2027)
6.6.2 USA Meningococcal Group B Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 USA Meningococcal Group B Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027
7.2 North America Meningococcal Group B Vaccine Market Facts & Figures by Country
7.2.1 North America Meningococcal Group B Vaccine Sales by Country (2016-2021)
7.2.2 North America Meningococcal Group B Vaccine Revenue by Country (2016-2021)
7.2.3 the United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Meningococcal Group B Vaccine Market Facts & Figures by Country
9.2.1 Europe Meningococcal Group B Vaccine Sales by Country (2016-2021)
9.2.2 Europe Meningococcal Group B Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 UK
9.2.6 Italy
10 Latin America
10.1 Latin America Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Meningococcal Group B Vaccine Market Facts & Figures by Country
10.2.1 Latin America Meningococcal Group B Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Meningococcal Group B Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Meningococcal Group B Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Meningococcal Group B Vaccine Products Offered
12.2.5 Pfizer Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Meningococcal Group B Vaccine Products Offered
12.11.5 GSK Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Meningococcal Group B Vaccine Industry Trends
13.2 Meningococcal Group B Vaccine Market Drivers
13.3 Meningococcal Group B Vaccine Market Challenges
13.4 Meningococcal Group B Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meningococcal Group B Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Meningococcal Group B Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Bexsero
Table 3. Major Manufacturers of Trumenba
Table 4. Major Manufacturers of Other
Table 5. Global Meningococcal Group B Vaccine Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Meningococcal Group B Vaccine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Meningococcal Group B Vaccine Sales by Regions (2016-2021) & (K Units)
Table 8. Global Meningococcal Group B Vaccine Sales Market Share by Regions (2016-2021)
Table 9. Global Meningococcal Group B Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Meningococcal Group B Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Meningococcal Group B Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Meningococcal Group B Vaccine Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Meningococcal Group B Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Meningococcal Group B Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Meningococcal Group B Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Meningococcal Group B Vaccine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Meningococcal Group B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Meningococcal Group B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Group B Vaccine as of 2020)
Table 21. Key Manufacturers Meningococcal Group B Vaccine Price (2016-2021) (USD/Unit)
Table 22. Meningococcal Group B Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Meningococcal Group B Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Meningococcal Group B Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Group B Vaccine Sales by Type (2016-2021) (K Units)
Table 27. Global Meningococcal Group B Vaccine Sales Share by Type (2016-2021)
Table 28. Global Meningococcal Group B Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Meningococcal Group B Vaccine Revenue Share by Type (2016-2021)
Table 30. Meningococcal Group B Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Meningococcal Group B Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Meningococcal Group B Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Meningococcal Group B Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Meningococcal Group B Vaccine Sales by Application (2016-2021) (K Units)
Table 37. Global Meningococcal Group B Vaccine Sales Share by Application (2016-2021)
Table 38. Global Meningococcal Group B Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Meningococcal Group B Vaccine Revenue Share by Application (2016-2021)
Table 40. Meningococcal Group B Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Meningococcal Group B Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Meningococcal Group B Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Meningococcal Group B Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. USA Meningococcal Group B Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 47. USA Meningococcal Group B Vaccine Sales Share by Company (2016-2021)
Table 48. USA Meningococcal Group B Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 49. USA Meningococcal Group B Vaccine Revenue Share by Company (2016-2021)
Table 50. USA Meningococcal Group B Vaccine Sales (K Units) by Type (2016-2021)
Table 51. USA Meningococcal Group B Vaccine Sales Share by Type (2016-2021)
Table 52. USA Meningococcal Group B Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. USA Meningococcal Group B Vaccine Price (USD/Unit) by Type (2016-2021)
Table 54. USA Meningococcal Group B Vaccine Sales (K Units) by Type (2022-2027)
Table 55. USA Meningococcal Group B Vaccine Sales Share by Type (2022-2027)
Table 56. USA Meningococcal Group B Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. USA Meningococcal Group B Vaccine Revenue Share by Type (2022-2027)
Table 58. USA Meningococcal Group B Vaccine Price (USD/Unit) by Type (2022-2027)
Table 59. USA Meningococcal Group B Vaccine Sales (K Units) by Application (2016-2021)
Table 60. USA Meningococcal Group B Vaccine Sales Share by Application (2016-2021)
Table 61. USA Meningococcal Group B Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. USA Meningococcal Group B Vaccine Price (USD/Unit) by Application (2016-2021)
Table 63. USA Meningococcal Group B Vaccine Sales (K Units) by Application (2022-2027)
Table 64. USA Meningococcal Group B Vaccine Sales Share by Application (2022-2027)
Table 65. USA Meningococcal Group B Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. USA Meningococcal Group B Vaccine Revenue Share by Application (2022-2027)
Table 67. USA Meningococcal Group B Vaccine Price (USD/Unit) by Application (2022-2027)
Table 68. North America Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
Table 69. North America Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
Table 70. North America Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region (2016-2021)
Table 76. Europe Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
Table 77. Europe Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
Table 78. Europe Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)
Table 88. GSK Corporation Information
Table 89. GSK Description and Business Overview
Table 90. GSK Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. GSK Meningococcal Group B Vaccine Product
Table 92. GSK Recent Development
Table 93. Pfizer Corporation Information
Table 94. Pfizer Description and Business Overview
Table 95. Pfizer Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Pfizer Product
Table 97. Pfizer Recent Development
Table 98. Meningococcal Group B Vaccine Market Trends
Table 99. Meningococcal Group B Vaccine Market Drivers
Table 100. Meningococcal Group B Vaccine Market Challenges
Table 101. Meningococcal Group B Vaccine Market Restraints
Table 102. Meningococcal Group B Vaccine Customers List
Table 103. Meningococcal Group B Vaccine Distributors List
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Group B Vaccine Product Picture
Figure 2. Global Meningococcal Group B Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Bexsero Product Picture
Figure 4. Trumenba Product Picture
Figure 5. Other Product Picture
Figure 6. Global Meningococcal Group B Vaccine Sales Market Share by Application in 2020 & 2027
Figure 7. Public
Figure 8. Private
Figure 9. Meningococcal Group B Vaccine Report Years Considered
Figure 10. Global Meningococcal Group B Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Meningococcal Group B Vaccine Market Size 2016-2027 (US$ Million)
Figure 12. Global Meningococcal Group B Vaccine Sales 2016-2027 (K Units)
Figure 13. Global Meningococcal Group B Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global Meningococcal Group B Vaccine Sales Market Share by Region in 2020
Figure 16. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2016-2021)
Figure 17. Global Meningococcal Group B Vaccine Revenue Market Share by Region in 2020
Figure 18. Global Meningococcal Group B Vaccine Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Group B Vaccine Revenue in 2020
Figure 20. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Meningococcal Group B Vaccine Sales Market Share by Type (2016-2021)
Figure 22. Global Meningococcal Group B Vaccine Sales Market Share by Type in 2020
Figure 23. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2016-2021)
Figure 24. Global Meningococcal Group B Vaccine Revenue Market Share by Type in 2020
Figure 25. Global Meningococcal Group B Vaccine Sales Market Share by Application (2016-2021)
Figure 26. Global Meningococcal Group B Vaccine Sales Market Share by Application in 2020
Figure 27. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2016-2021)
Figure 28. Global Meningococcal Group B Vaccine Revenue Market Share by Application in 2020
Figure 29. USA Meningococcal Group B Vaccine Sales Growth Rate 2016-2027 (K Units)
Figure 30. USA Meningococcal Group B Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. USA Meningococcal Group B Vaccine Market Share in Global Market 2016-2027
Figure 32. USA 5 and 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue in Meningococcal Group B Vaccine in 2020
Figure 33. USA Meningococcal Group B Vaccine Revenue Share by Type (2016-2021)
Figure 34. USA Meningococcal Group B Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 35. USA Meningococcal Group B Vaccine Revenue Share by Application (2016-2021)
Figure 36. USA Meningococcal Group B Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Meningococcal Group B Vaccine Sales Market Share by Country in 2020
Figure 40. North America Meningococcal Group B Vaccine Revenue Market Share by Country in 2020
Figure 41. the United States Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 42. the United States Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Meningococcal Group B Vaccine Sales Market Share by Country in 2020
Figure 48. Europe Meningococcal Group B Vaccine Revenue Market Share by Country in 2020
Figure 49. Germany Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. UK Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 54. UK Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 60. Asia Pacific Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region in 2020
Figure 62. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region in 2020
Figure 63. China Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 64. China Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 66. Japan Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 68. South Korea Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 70. India Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 72. Australia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 74. China Taiwan Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 76. Indonesia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 78. Thailand Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 80. Malaysia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 82. Latin America Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Meningococcal Group B Vaccine Sales Market Share by Country in 2020
Figure 84. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country in 2020
Figure 85. Mexico Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 86. Mexico Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 88. Brazil Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 90. Argentina Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Middle East and Africa Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 92. Middle East and Africa Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country in 2020
Figure 94. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country in 2020
Figure 95. Turkey Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 96. Turkey Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Saudi Arabia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 98. Saudi Arabia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. UAE Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 100. UAE Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Meningococcal Group B Vaccine Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs